A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
This study has been completed.
First Posted: July 18, 2007
Last Update Posted: August 18, 2017
Information provided by (Responsible Party):